<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.11 --><!--Automatically converted from version 2.3 to 2.4-->

<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>

   <PublisherInfo>

      <PublisherName>Springer-Verlag</PublisherName>

      <PublisherLocation>Berlin Heidelberg</PublisherLocation>

   </PublisherInfo>

   <Journal>

      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">

         <JournalID>105</JournalID>

         <JournalPrintISSN>0017-8470</JournalPrintISSN>

         <JournalSPIN/>

         <JournalTitle>Der Hautarzt</JournalTitle>

         <JournalSubTitle>Zeitschrift für Dermatologie, Allergologie, Venerologie und verwandte Gebiete</JournalSubTitle>

         <JournalAbbreviatedTitle>Hautarzt</JournalAbbreviatedTitle>
         <JournalSubjectGroup>
            <JournalSubject Type="Primary">Legacy</JournalSubject>
         </JournalSubjectGroup>

      </JournalInfo>

      <Volume>

         <VolumeInfo VolumeType="Regular">
            <VolumeIDStart>46</VolumeIDStart>
            <VolumeIDEnd>46</VolumeIDEnd>
            <VolumeIssueCount/>
         </VolumeInfo>

         <Issue IssueType="Regular">

            <IssueInfo TocLevels="0">

               <IssueIDStart>2</IssueIDStart>

               <IssueIDEnd>2</IssueIDEnd>

               <IssueHistory>

                  <PrintDate>

                     <Year>1995</Year>

                     <Month>2</Month>

                     <Day/>

                  </PrintDate>

                  <CoverDate>

                     <Year>1995</Year>

                     <Month>2</Month>

                  </CoverDate>

               </IssueHistory>

               <IssueCopyright>

                  <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                  <CopyrightYear>1995</CopyrightYear>

               </IssueCopyright>

            </IssueInfo>

            <Article ID="Art1">

               <ArticleInfo Language="En" ArticleType="OriginalPaper" NumberingStyle="Unnumbered" ContainsESM="No" TocLevels="0">

                  <ArticleID>50460102.105</ArticleID>

                  <ArticleDOI>10.1007/s001050050217</ArticleDOI>

                  <ArticleTitle Language="De">Substanz P und vasoaktives intestinales Peptid bei Patienten mit progressiver Sklerodermie
</ArticleTitle>

                  <ArticleSubTitle Language="De">Plasmaspiegelbestimmungen vor und nach autogenem Training</ArticleSubTitle>

                  <ArticleTitle Language="En">Substance P and vasoactive intestinal peptide in patients with progressive systemic sclerosis. Plasma levels before and after autogenic training</ArticleTitle>

                  <ArticleCategory/>

                  <ArticleFirstPage>102</ArticleFirstPage>

                  <ArticleLastPage>106</ArticleLastPage>

                  <ArticleCopyright>

                     <CopyrightHolderName>Springer-Verlag Berlin Heidelberg</CopyrightHolderName>

                     <CopyrightYear>1995</CopyrightYear>

                  </ArticleCopyright>
                  <ArticleGrants>
                     <MetadataGrant Grant="OpenAccess"/>
                     <AbstractGrant Grant="OpenAccess"/>
                     <BodyPDFGrant Grant="Restricted"/>
                     <BodyHTMLGrant Grant="Restricted"/>
                     <BibliographyGrant Grant="Restricted"/>
                     <ESMGrant Grant="Restricted"/>
                  </ArticleGrants>

               </ArticleInfo>

               <ArticleHeader>

                  <AuthorGroup>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Uwe-Fritjof</GivenName>

                           <FamilyName>Haustein</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>Brigitte</GivenName>

                           <FamilyName>Weber</FamilyName>

                        </AuthorName>

                     </Author>

                     <Author AffiliationIDS="A1">

                        <AuthorName DisplayOrder="Western">

                           <GivenName>K.</GivenName>

                           <FamilyName>Seikowski</FamilyName>

                        </AuthorName>

                     </Author>

                     <Affiliation ID="A1">

                        <OrgName>Klinik und Poliklinik für Hautkrankheiten (Direktor: Prof. Dr. U.-F. Haustein) der Universität Leipzig</OrgName>

                        <OrgAddress>

                           <Street/>

                           <Postbox/>

                           <Postcode/>

                           <City/>

                           <State/>

                           <Country>DE</Country>

                        </OrgAddress>

                     </Affiliation>

                  </AuthorGroup>

                  <Abstract ID="Abs1" Language="De">

                     <Heading>Zusammenfassung.</Heading>

                     <Para> Bei 12 Patienten mit progressiver Sklerodermie (PS) wurde der Einfluß des autogenen Trainings (AT) auf den Plasmaspiegel der Neuropeptide, Substanz P und vasoaktives intestinales Peptid untersucht. Im Vergleich zu gesunden Kontrollen (N) besaßen die Sklerodermiepatienten signifikant erhöhte Substanz-P-Plasmaspiegel (x±s: PS-Patienten 7,1±3,2 pmol/l, N 1,6±1,6 pmol/l). Die VIP-Plasmakonzentrationen zeigten, abgesehen von punktuellen Abweichungen, keine wesentlichen Unterschiede zu den Normwerten (x±s: PS-Patienten 10,7±7,1 pmol/l, N 12,0±5,3 pmol/l). Mittels autogenen Trainings waren keine wesentlichen Neuropeptidplasmaspiegeländerungen zu erzielen.</Para>

                  </Abstract>

                  <Abstract ID="Abs2" Language="En">

                     <Heading>Abstract.</Heading>

                     <Para> In 12 patients suffering from systemic sclerosis (SSc) the influence of autogenic training on the plasma level of the neuropeptides substance P and vasoactive intestinal peptide (VIP) was studied. Compared with healthy controls the SSc patients exhibited significantly elevated levels of substance P (mean±SD: 7.1±3.2 pmol/l vs 1.6±1.6 pmol/l). Apart from variations the VIP plasma concentration did not significantly differ from that in healthy controls (mean±SD: 10.7±7.1 pmol/l versus 12.0±5.3 pmol/l). Autogenic training did not bring about any significant changes in the plasma levels of neuropeptides.</Para>

                  </Abstract>

                  <KeywordGroup Language="En">

                     <Keyword>Schlüsselwörter: Progressive Sklerodermie – Neuropeptide – Plasmaspiegel – Substanz P – Vasoaktives intestinales Peptid – Autogenes Training</Keyword>

                  </KeywordGroup>

                  <KeywordGroup Language="En">

                     <Keyword>Key words: Systemic sclerosis – Neuropeptides – Plasma level – Substance P – Vasoactive intestinal peptide – Autogenic training</Keyword>

                  </KeywordGroup>

               </ArticleHeader>

               <NoBody/>

            </Article>

         </Issue>

      </Volume>

   </Journal>

</Publisher>